IPSC Century Therapeutics, Inc.

Fundamentals / CIK 0001850119 / USD

Century Therapeutics, Inc. reported $109.2M in revenue and a net loss of $98.82M for the fiscal year ended December 31, 2025 (up 1556.8% year over year), with a -97.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open IPSC in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$122.0M$61.01M$0-$137.1MFY 2020 Net Income: -$53.58M2020FY 2021 Net Income: -$95.82M2021FY 2022 Revenue: $5.20MFY 2022 Net Income: -$130.9M2022FY 2023 Revenue: $2.23MFY 2023 Net Income: -$136.7M2023FY 2024 Revenue: $6.59MFY 2024 Net Income: -$126.6M2024FY 2025 Revenue: $109.2MFY 2025 Net Income: -$9.58M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $109.2M $6.59M $2.23M $5.20M -- --
Research & Development $95.67M $107.2M $92.71M $97.17M $75.65M $39.68M
Total Operating Expenses $126.4M $144.7M $148.8M $139.0M $94.88M $53.90M
Operating Income -$17.27M -$138.1M -$146.5M -$133.8M -$94.88M -$53.90M
EBITDA -$4.17M -$124.8M -$133.5M -$125.4M -$91.14M -$52.50M
Interest Income $7.35M $13.01M $12.68M -- -- --
Interest Expense -- -- $540K $1.02M $1.27M $381K
Income Before Tax -$9.65M -$124.8M -$134.8M -$130.8M -$95.78M -$53.58M
Income Tax Expense -$68K $1.79M $1.88M $91K $43K --
Net Income -$9.58M -$126.6M -$136.7M -$130.9M -$95.82M -$53.58M
Basic EPS -$0.14 -$1.61 -$2.30 -$2.27 -$2.96 -$7.16
Diluted EPS -$0.14 -$1.61 -$2.30 -$2.96 -$2.96 -$7.16
Basic Shares Outstanding 86.6M 78.6M 59.3M 57.8M 32.4M 7.5M
Diluted Shares Outstanding 86.6M 78.6M 59.3M 32.4M 32.4M 7.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- $0 $0 $0 $109.2M $4.17M
Research & Development $18.06M $19.59M $17.11M $19.70M $12K $26.86M $26.58M $29.38M
Total Operating Expenses $25.21M $36.53M $23.68M $20.65M $36.12M $34.66M $34.99M $41.46M
Operating Income -$25.21M -$36.53M -$23.68M -$20.65M -$36.12M -$34.66M $74.18M -$37.28M
EBITDA -$23.02M -$36.50M -$20.68M -$17.10M -$32.99M -$31.46M $77.40M -$33.97M
Interest Income $1.75M $1.98M $2.02M $1.31M $1.60M $2.01M $2.42M $2.88M
Income Before Tax -- -- -- -$19.24M -$34.42M -$32.54M $76.56M -$34.30M
Income Tax Expense -- -- -- -- -- -- -- $1.78M
Net Income -$23.45M -$34.55M -$21.64M -$19.17M -$34.42M -$32.54M $76.56M -$36.07M
Basic EPS -$0.11 -$0.17 -$0.11 -- -$0.40 -$0.38 $0.89 --
Diluted EPS -$0.11 -$0.17 -$0.11 -- -$0.40 -$0.38 $0.89 --
Basic Shares Outstanding 206.4M 205.8M 193.5M -- 86.5M 86.2M 86.0M --
Diluted Shares Outstanding 206.4M 205.8M 193.5M -- 86.5M 86.2M 86.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $61.85M $58.44M $47.32M $84.27M $56.45M $27.21M
Short-Term Investments $55.26M $130.9M $125.4M $231.2M $166.4M $48.54M
Cash & Short-Term Investments $117.1M $189.3M $172.7M $315.5M $222.9M $75.75M
Other Current Assets -- -- $1.57M -- $250K $256K
Total Current Assets $120.8M $194.1M $177.0M $319.7M $228.2M $78.80M
Property, Plant & Equipment, Net $50.03M $62.14M $71.70M $82.78M $57.97M $15.38M
Intangible Assets $34.20M $34.20M -- -- -- --
Long-Term Investments -- $30.82M $89.10M $51.85M $135.9M $1.05M
Total Non-Current Assets $102.9M $159.2M $183.7M $166.8M $209.2M $27.98M
Total Assets $223.7M $353.2M $360.7M $486.5M $437.4M $106.8M
Accounts Payable $4.77M $3.08M $2.74M $5.45M $7.60M $8.08M
Deferred Revenue (Current) -- $109.2M $4.37M $7.15M -- --
Other Current Liabilities -- $75K $28K $236K -- --
Total Current Liabilities $20.23M $129.8M $17.85M $29.82M $15.65M $12.11M
Long-Term Debt -- -- -- $3.74M $8.90M $9.64M
Deferred Revenue (Non-Current) -- -- $111.4M $110.8M -- --
Total Non-Current Liabilities $44.54M $62.07M $158.1M $154.0M $25.48M $21.32M
Total Liabilities $64.77M $191.9M $175.9M $183.8M $41.14M $33.43M
Total Debt (incl. Leases) $43.56M $53.83M $48.17M $49.41M $25.12M $21.55M
Common Stock $9.0K $9.0K $6.0K $6.0K $5.0K $1.0K
Retained Earnings -$791.9M -$782.3M -$655.8M -$519.1M -$388.2M -$292.3M
Accumulated Other Comp. Income $30K $324K $108K -$2.46M -$650K -$3.0K
Total Stockholders' Equity $158.9M $161.4M $184.8M $302.7M $396.2M -$106.4M
Total Equity $158.9M $161.4M $184.8M $302.7M $396.2M -$106.4M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $45.02M $49.64M $51.05M $61.85M $55.52M $56.88M $51.87M $58.44M
Short-Term Investments $72.19M $70.07M $83.75M $55.26M $77.23M $98.97M $113.3M $130.9M
Cash & Short-Term Investments $117.2M $119.7M $134.8M $117.1M $132.7M $155.8M $165.1M $189.3M
Total Current Assets $122.7M $124.8M $139.0M $120.8M $137.7M $160.2M $169.6M $194.1M
Property, Plant & Equipment, Net $32.83M $34.48M $47.61M $50.03M $53.72M $56.65M $59.53M $62.14M
Intangible Assets $34.20M $34.20M $34.20M $34.20M $34.20M $34.20M $34.20M $34.20M
Long-Term Investments $56.92M $77.48M $82.17M -- -- $2.69M $20.71M $30.82M
Total Non-Current Assets $139.9M $162.2M $187.5M $102.9M $107.0M $124.5M $146.0M $159.2M
Total Assets $262.6M $287.0M $326.6M $223.7M $244.7M $284.7M $315.6M $353.2M
Accounts Payable $2.98M $4.82M $3.15M $4.77M $2.62M $3.21M $3.57M $3.08M
Deferred Revenue (Current) -- -- -- -- -- -- -- $109.2M
Other Current Liabilities -- -- -- -- $1.03M $49K $111K $75K
Total Current Liabilities $14.04M $15.07M $13.57M $20.23M $22.03M $14.95M $14.50M $129.8M
Other Non-Current Liabilities $666K $666K -- -- -- -- -- --
Total Non-Current Liabilities $38.61M $39.59M $48.24M $44.54M $46.34M $59.85M $60.67M $62.07M
Total Liabilities $52.66M $54.66M $61.81M $64.77M $68.37M $74.79M $75.17M $191.9M
Total Debt (incl. Leases) $37.49M $38.67M $48.02M $43.56M $44.96M $51.48M $52.67M $53.83M
Common Stock $18K $18K $18K $9.0K $9.0K $9.0K $9.0K $9.0K
Retained Earnings -$871.6M -$848.1M -$813.6M -$791.9M -$772.7M -$738.3M -$705.8M -$782.3M
Accumulated Other Comp. Income -$1.14M -$694K -$585K $30K $64K $83K $305K $324K
Total Stockholders' Equity $210.0M $232.3M $264.7M $158.9M $176.3M $209.9M $240.4M $161.4M
Total Equity $210.0M $232.3M $264.7M $158.9M $176.3M $209.9M $240.4M $161.4M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$9.58M -$126.6M -$136.7M -$130.9M -$95.82M -$53.58M
Depreciation & Amortization $13.10M $13.30M $13.04M $8.44M $3.75M $1.40M
Stock-Based Compensation $6.84M $12.69M $14.62M $10.67M $4.66M $876K
Change in Payables $1.56M -$1.47M -$2.36M -$4.79M -$1.85M $2.06M
Operating Cash Flow -$103.9M -$110.1M -$88.35M $14.05M -$89.00M -$41.27M
Capital Expenditure -$848K -$154K -$13.74M -$30.60M -$44.97M -$9.82M
Free Cash Flow -$104.7M -$110.3M -$102.1M -$16.55M -$134.0M -$51.09M
Purchases of Investments -$51.17M -$119.5M -$209.0M -$254.0M -$330.0M -$49.86M
Investing Cash Flow $107.5M $47.48M $61.13M -$13.13M -$298.3M -$22.76M
Common Stock Issued $173K $141K $516K $345K $213K --
Financing Cash Flow $173K $74.56M -$9.72M $27.16M $417.8M $47.69M
Net Change in Cash $3.80M $11.91M -$36.94M $28.08M $30.43M --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$23.45M -$34.55M -$21.64M -$19.17M -$34.43M -$32.54M $76.56M -$36.07M
Depreciation & Amortization $2.19M $26K $3.00M $3.55M $3.13M $3.20M $3.22M $3.32M
Stock-Based Compensation $1.44M $1.95M $1.45M $1.30M $892K $2.22M $2.43M $2.66M
Change in Payables -$1.84M $1.67M -$1.62M $2.16M -$591K -$365K $361K $477K
Operating Cash Flow -$22.23M -$19.83M -$25.26M -$16.08M -$25.58M -$27.59M -$34.62M -$24.22M
Capital Expenditure -$535K -$694K -$584K $139K -$195K -$317K -$475K --
Free Cash Flow -$22.76M -$20.53M -$25.85M -$15.94M -$25.78M -$27.91M -$35.10M --
Purchases of Investments -$1.31M -$15.97M -$140.7M -$15.60M -$11.02M -$9.67M -$14.88M -$17.40M
Investing Cash Flow $17.53M $17.77M -$112.6M $22.36M $24.67M $32.54M $27.93M $30.61M
Common Stock Issued $76K $347K $202K $53K $0 $0 $120K -$602K
Financing Cash Flow $76K $311K $126.6M $53K $0 $0 $120K -$602K
Net Change in Cash -$4.63M -$1.76M -$11.25M $6.34M -$913K $4.95M -$6.57M $5.78M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -15.8% -2096.5% -6556.9% -2574.2% -- --
Net Profit Margin -8.8% -1920.9% -6115.1% -2518.4% -- --
Return on Equity (ROE) -6.0% -78.4% -74.0% -43.2% -24.2% --
Return on Assets (ROA) -4.3% -35.8% -37.9% -26.9% -21.9% -50.2%
Current Ratio 5.97x 1.50x 9.92x 10.72x 14.57x 6.51x
Quick Ratio 5.79x 1.46x 9.68x 10.58x 14.24x 6.25x
Debt to Equity 0.27x 0.33x 0.26x 0.16x 0.06x --
Revenue Growth (YoY) +1556.8% +194.8% -57.0% -- -- --
Operating Cash Flow Growth (YoY) -- -- -728.7% -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -15.8% -29.9% -28.5% -28.4% -2096.2%
Net Profit Margin -- -- -- -8.8% -23.4% -20.4% -19.1% -1920.6%
Return on Equity (ROE) -47.1% -47.3% -40.7% -6.0% -15.0% -11.1% -9.1% -78.4%
Return on Assets (ROA) -37.6% -38.3% -33.0% -4.3% -10.8% -8.2% -7.0% -35.8%
Current Ratio 8.74x 8.28x 10.25x 5.97x 6.25x 10.72x 11.70x 1.50x
Quick Ratio 8.34x 7.94x 9.94x 5.79x 6.03x 10.43x 11.39x 1.46x
Debt to Equity 0.18x 0.17x 0.18x 0.27x 0.25x 0.25x 0.22x 0.33x
Revenue Growth (YoY) -- -- -- -100.0% -100.0% -100.0% +12667.7% +1457.1%
Operating Income Growth (YoY) -- -- -131.9% -- -- -- -- --
Net Income Growth (YoY) -- -- -128.3% -- -- -- -- --
EPS Growth (YoY) -- -- -112.4% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001850119) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:40 UTC · Open in terminal